Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/spandidos-publications/correlation-of-adverse-effects-of-cisplatin-administration-in-patients-0T2l8Ca7n7
References (53)
-
Arthur Schierl (2000)
Urinary Excretion of Platinum in Chemotherapy-treated Long-term Survivors of Testicular CancerActa Oncologica, 39
-
M. Kartalou, J. Essigmann (2001)
Mechanisms of resistance to cisplatin.Mutation research, 478 1-2
-
Rivera (2007)
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaClin Transl Oncol, 9
-
J. Uhm, Ho Lim, W. Kim, H. Choi, H. Lee, Byeong-Bae Park, Keunchil Park, W. Kang (2007)
Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.Neoplasia, 9 1
-
F. Rivera, M. Vega-Villegas, M. López-Brea, A. García-Castaño, A. Juan, F. Ramos, A. Collado, P. Galdós, A. Rubio, A. Valle, J. Rama, M. Mayorga, J. Sanz‐Ortiz (2007)
Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck CarcinomaClinical and Translational Oncology, 9
-
C. Rabik, M. Dolan (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents.Cancer treatment reviews, 33 1
-
J. Lautermann, B. Song, J. McLaren, J. Schacht (1995)
Diet is a risk factor in cisplatin ototoxicityHearing Research, 88
-
M. Bosch, A. Sánchez, F. Rojas, C. Ojeda (2008)
Analytical methodologies for the determination of cisplatin.Journal of pharmaceutical and biomedical analysis, 47 3
-
M. Drottar, M. Liberman, R. Ratan, D. Roberson (2006)
The Histone Deacetylase Inhibitor Sodium Butyrate Protects Against Cisplatin‐Induced Hearing Loss in Guinea PigsThe Laryngoscope, 116
-
D. Armstrong, M. Bookman, W. Mcguire, R. Bristow, J. Schilder (2007)
A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study.Gynecologic oncology, 105 3
-
L. Astolfi, E. Simoni, A. Ciorba, A. Martini (2008)
In vitro protective effects of Ginkgo biloba against cisplatin toxicity in mouse cell line OCk3Audiological Medicine, 6
-
R. Gregg, J. Molepo, V Monpetit, N Mikael, D. Redmond, M. Gadia, D. Stewart (1992)
Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 5
-
Alper Daldal, O. Odabaşı, B. Serbetcioglu (2007)
The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigsOtolaryngology–Head and Neck Surgery, 137
-
H. Timmer‐Bosscha, Nanno Mulder, de Vries (1992)
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.British Journal of Cancer, 66
-
M. Kris, P. Hesketh, M. Somerfield, P. Feyer, R. Clark-Snow, J. Koeller, G. Morrow, L. Chinnery, Maurice Chesney, R. Gralla, S. Grunberg (2006)
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18
-
Elizabeth Blanchard (2012)
Cisplatin and solid tumors: Still working, after all these yearsJournal of Solid Tumors, 2
-
(2007)
Reportistica predefinita REM: anno 2006. (updated Available from -
V. Schweitzer (1993)
Cisplatin‐Induced Ototoxicity: The Effect of Pigmentation and Inhibitory AgentsThe Laryngoscope, 103
-
A. Adjei, I. Budihardjo, E. Rowinsky, Timothy Kottke, P. Svingen, C. Buckwalter, L. Grochow, R. Donehower, S. Kaufmann, Mayo Clinic, Minnesota Rochester (1997)
Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 5
-
J. Gietema, M. Meinardi, J. Messerschmidt, T. Gelevert, Florian Alt, D. Uges, D. Sleijfer (2000)
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancerThe Lancet, 355
-
M. Previati, I. Lanzoni, E. Corbacella, S. Magosso, S. Giuffré, F. Francioso, D. Arcelli, S. Volinia, Andrea Barbieri, S. Hatzopoulos, S. Capitani, A. Martini (2004)
RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell lineHearing Research, 196
-
M. Gosland, B. Lum, Julia Schimmelpfennig, James Baker, M. Doukas (1996)
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical ReversalPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 16
-
M. Tiseo, A. Ardizzoni (2011)
Chemotherapy in the treatment of thymic tumorsOncology Reviews, 2
-
K. Cullen, Zejia Yang, L. Schumaker, Zhongmin Guo (2007)
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancerJournal of Bioenergetics and Biomembranes, 39
-
S. Hatzopoulos, M. Stefano, A. Albertin, A. Martini (1999)
Evaluation of Cisplatin Ototoxicity in a Rat Animal ModelAnnals of the New York Academy of Sciences, 884
-
M. Previati, I. Lanzoni, E. Corbacella, S. Magosso, V. Guaran, A. Martini, S. Capitani (2006)
Cisplatin-induced apoptosis in human promyelocytic leukemia cells.International journal of molecular medicine, 18 3
-
William Chen, A. Jackson, A. Budnick, D. Pfister, D. Kraus, M. Hunt, H. Stambuk, S. Levegrun, S. Wolden (2005)
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinomaCancer, 106
-
Keun-Wook Lee, J. Kim, T. Yun, E. Song, I. Na, Hyunchoon Shin, S. Oh, I. Choi, D. Oh, Dong-Wan Kim, S. Im, Tae-You Kim, J. Lee, D. Heo, Y. Bang, N. Kim (2007)
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric CancerJournal of Korean Medical Science, 22
-
N. Girard, F. Mornex, P. Houtte, J. Cordier, P. Schil (2009)
Thymoma: a focus on current therapeutic management.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 4 1
-
R. Deconti, B. Toftness, R. Lange, W. Creasey (1973)
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).Cancer research, 33 6
-
N. Hanna (2006)
Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732Yearbook of Oncology, 2006
-
K. Tewari, B. Monk (2005)
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancerCurrent Oncology Reports, 7
-
R. Go, A. Adjei (1999)
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
-
(2012)
Available from: http://cancer -
J. Hohnloser, R. Schierl, B. Hasford, B. Emmerich (1996)
Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.European journal of medical research, 1 11
-
E. Vokes (2010)
Induction chemotherapy for head and neck cancer: recent data.The oncologist, 15 Suppl 3
-
K. Ridwelski, T. Gebauer, J. Fahlke, H. Kröning, E. Kettner, F. Meyer, K. Eichelmann, Hans Lippert (2001)
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 12 1
-
E. Atallah, L. Flaherty (2005)
Treatment of metastatic malignant melanomaCurrent Treatment Options in Oncology, 6
-
F. Tanaka, C. Whitworth, L. Rybak (2003)
Influence of pH on the ototoxicity of cisplatin: a round window application studyHearing Research, 177
-
H. Arafa, Mostafa Abdel-Hamid, A. El-Khouly, M. Elmazar, A. Osman (2006)
Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm.Toxicology, 222 1-2
-
J. Mendelson, Dana McGlothlin, D. Harris, E. Foster, T. Everhart, Peyton Jacob, Reese Jones (2008)
The Clinical Pharmacology of Intranasal l-MethamphetamineBMC Clinical Pharmacology, 8
-
Niell (2005)
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732J Clin Oncol, 23
-
M. Previati, I. Lanzoni, L. Astolfi, F. Fagioli, G. Vecchiati, A. Pagnoni, A. Martini, S. Capitani (2007)
Cisplatin cytotoxicity in organ of corti‐derived immortalized cellsJournal of Cellular Biochemistry, 101
-
L. Bertolaso, A. Martini, Debora Bindini, I. Lanzoni, Alina Parmeggiani, C. Vitali, G. Kalinec, F. Kalinec, S. Capitani, M. Previati (2001)
Apoptosis in the OC-k3 Immortalized Cell Line Treated with Different Agents: Apoptosis en linea celular OC k3 inmortalizada, tratada con diferentes agentesAudiology, 40
-
J. Rademaker-Lakhai, M. Crul, D. Pluim, R. Sparidans, P. Baas, J. Beijnen, N. Zandwijk, J. Schellens (2005)
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancerAnti-Cancer Drugs, 16
-
C. Zuur, Y. Simis, Roxanna Verkaik, J. Schornagel, A. Balm, W. Dreschler, C. Rasch (2008)
Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 89 1
-
M. Hyppolito, J. Oliveira, M. Rossato (2006)
Cisplatin ototoxicity and otoprotection with sodium salicylateEuropean Archives of Oto-Rhino-Laryngology and Head & Neck, 263
-
U. Chaudhary, Jason Haldas (2012)
Long-Term Complications of Chemotherapy for Germ Cell TumoursDrugs, 63
-
L. Rybak, C. Whitworth (2005)
Ototoxicity: therapeutic opportunities.Drug discovery today, 10 19
-
H. Maase (2002)
Current and future perspectives in advanced bladder cancer: is there a new standard?Seminars in oncology, 29 1 Suppl 3
-
J. Berg, J. Beijnen, A. Balm, J. Schellens (2006)
Future opportunities in preventing cisplatin induced ototoxicity.Cancer treatment reviews, 32 5
-
P. Tothill, H. Klys, L. Matheson, K. Mckay, J. Smyth (1992)
The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.European journal of cancer, 28A 8-9
-
Brouwers (2008)
Long-term platinum retention after treatment with cisplatin and oxaliplatinBMC Clin Pharmacol, 8
- Publisher
- Spandidos Publications
- Copyright
- Copyright © Spandidos Publications
- ISSN
- 1021-335X
- eISSN
- 1791-2431
- DOI
- 10.3892/or.2013.2279
- pmid
- 23404427
- Publisher site
- See Article on Publisher Site
Abstract
Cisplatin is the most common antineoplastic drug used for the therapy of solid tumours. To date, researchers have focused on the dosage to be administered for each specific tumour, mainly considering the local adverse effects. The aim of this study was to correlate the severity of the adverse effects with: i) the dosage of cisplatin; ii) the specific site of the tumour; iii) the association with other drugs; and iv) the symptoms. We analysed data from 123 patients with 11 different tumour classes undergoing therapy from 2007 to 2008 at St. Anna Hospital (Ferrara, Italy), using the Spearman non-parametric correlation index. Even though significant correlations were found among the variables, the overall results showed that the main factor influencing the severity of the adverse effects was the dosage of cisplatin administered.
Journal
Oncology Reports – Spandidos Publications
Published: Apr 1, 2013